From Infancy to Adolescence: Fifteen Years of Continuous Treatment With Hydroxyurea in Sickle Cell Anemia

Despite documented laboratory and clinical benefits of hydroxyurea for children with sickle cell anemia (SCA), the drug's long-term safety and efficacy remains poorly defined. The HUSOFT trial and extension study examined feasibility, toxicity, and hematological efficacy of hydroxyurea in infan...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Medicine (Baltimore)
Main Authors: Hankins, Jane S., Aygun, Banu, Nottage, Kerri, Thornburg, Courtney, Smeltzer, Matthew P., Ware, Russell E., Wang, Winfred C.
Format: Artigo
Jezik:Inglês
Izdano: Wolters Kluwer Health 2014
Teme:
4800
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4603125/
https://ncbi.nlm.nih.gov/pubmed/25526439
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000000215
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki